Here are seven articles published by Becker's Hospital Review this week detailing the Food and Drug Administration's crackdown on companies advertising fake cancer products, an Illinois city's lawsuit against Mallinckrodt Pharmaceuticals over high drug prices and more.
1. GHX recognizes 2017 healthcare supply chain leaders
Global Healthcare Exchange on Tuesday named the winners of its 2017 GHXcellence Award.
2. Pharmacist lobby group: PBMs prioritize profits over medication affordability
The National Community Pharmacists Association released a new report highlighting how pharmacy benefit managers contribute to high prescription drug costs.
3. FDA targets 14 companies advertising fake cancer products
The FDA is cracking down on companies fraudulently promoting their products as cancer treatments.
4. Critics question FDA nominee's involvement in Cephalon's 2006 fentanyl shortage
Critics of Scott Gottlieb, MD — President Donald Trump's pick to head the Food and Drug Administration — question his involvement in helping the drugmaker Cephalon acquire more fentanyl during a 2006 shortage.
5. Q1 pharma results: How 6 drugmakers stacked up
Here are six drugmakers' financial results for the first quarter of fiscal year 2017.
6. Illinois city sues Mallinckrodt over price of hormone drug: 4 takeaways
The city of Rockford, Ill., filed a lawsuit April 6 against Mallinckrodt Pharmaceuticals over the price of its hormone drug, H.P Acthar.
7. Survey: 99% of healthcare leaders concerned about drug price hikes
A majority of healthcare leaders cite high drug costs as a major challenge for their organization.
More articles on supply chain:
3 things to know about National Prescription Drug Take Back Day
Q1 pharma results: How 6 drugmakers stacked up
Prodigo Solutions taps ECRI Institute for real-time product safety alerts